chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: RSV
Symptoms: Injection site warmth, Pain
Clinical narrative: Pain at injection site, slightly raised large red circle around injection site, arm is warm to the touch, fatigue, headache.  This started the day of vaccine and has continued every day since. It has been 6 days since patient was vaccinated.   She has been taking Advil and Tylenol for pain.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Anxiety, Auscultation, COVID-19
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Confusional state, Decubitus ulcer, Dementia, Depression, Electrocardiogram normal
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Encephalopathy, Exposure to SARS-CoV-2, General physical condition abnormal, General physical health deterioration, Hyperkalaemia
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperlipidaemia, Hypertension, Hypoglycaemia, Hypotension, Illness
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inflammatory marker increased, Intensive care, Lethargy, Mental status changes, Metabolic encephalopathy
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Migraine, Pyrexia, Rales, Rhabdomyolysis, SARS-CoV-2 test negative
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sepsis, Septic shock, Tachycardia, Tachypnoea, Troponin increased
Clinical narrative: Patient is a confused 82-year-old female presented to the emergency department today from the nursing home for chief complaint of fever and altered mental status.  Patient is a poor historian at this time and appears quite ill.  Reportedly nursing home is having a increase in COVID-positive cases.  Patient was just recently discharged from the hospital on 08/08 for concern of suspected dementia and acute rhabdomyolysis.  Nursing home did a point-of-care COVID test today with a negative result.  They did bring her in for lethargy and altered mental status.  During exam patient is able to wake up and answers 1 question before she falls back asleep.  Patient is acutely ill and being transferred to ICU.  Unable to participate in collection of history.    Work-up in the ED: As above patient does initially meet sepsis criteria with COVID-19, tachycardia, tachypnea, hypotension after fluid bolus, and temperature of 104 °F.  Was given 1500 mL bolus, and cefepime in the ED.  Patient is still notably tachycardic and tachypneic after bolus.  Condition continued to deteriorate upon arrival to the ICU under intermediate status with hypotension after bolus as well as crackles noted on auscultation, patient was started on Levophed.  Initial troponin elevated at 40, second troponin 44, EKG shows no acute signs of ischemia per my view, likely secondary to AKI and hypotension.  Inflammatory markers elevated.  Patient is admitted under critical care status to the hospital service for further work-up and continuation of care.   Clinical Summary Patient was found to have covid contributing to her sepsis and acute respiratory failure as well as encephalopathy.  Patient was started on dexamethasone and remdesivir and patient was weaned back to room air without need for intubation during hospitalization and has been afebrile for greater than 24hrs with the rest of her VS and labs stable.  Patient will be discharged to SNF with dexamethasone 6mg PO daily x6 days with instructions to follow up with PCP.     Discharge diagnosis Septic shock secondary to COVID 19 Acute hypoxic respiratory failure secondary to COVID 19 Acute metabolic encephalopathy Elevated troponin AKI Hypoglycemia Hyperkalemia Hypertension Dementia Anxiety Depression Hyperlipidemia Migraines Sacral ulcer
Age: 85.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Fall, Mobility decreased
Clinical narrative: PATIENT GOT DIZZY AND FELL THE NIGHT FOLLOWING THE VACCINATION AT ABOUT 11PM. SHE WAS UNABLE TO GET UP,  THE NEXT DAY (SUNDAY) EMERGENCY WAS CALLED AT 4PM, AND SHE WAS TAKEN TO THE HOSPITAL WHERE SHE STAYED FOR 2 DAYS, AND WENT TO A REHABILITATION FACILITY AFTERWARDS FOR SEVERAL MORE DAYS
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Dysarthria, Erythema, Fall, Gait disturbance, Hallucination
Clinical narrative: slurring of words, sleeping all day, hallucination, difficalt walking, and falling. This lasted for about 12 hours On September 16 and 17 arm that shot was given in hurt badly and on the 17th two red spots showed up on arm.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity, Somnolence
Clinical narrative: slurring of words, sleeping all day, hallucination, difficalt walking, and falling. This lasted for about 12 hours On September 16 and 17 arm that shot was given in hurt badly and on the 17th two red spots showed up on arm.
Age: 69.0
Sex: F
Vaccine: RSV
Symptoms: Headache, Immediate post-injection reaction, Injection site pruritus, Injection site reaction, Nausea
Clinical narrative: Headache, redness and itchiness at  injection site, nausea; patient says side effects started immediately and lasted for 1 week
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray, Chronic respiratory failure, Condition aggravated
Clinical narrative: Patient is a 75 y.o. female patient of CNP with history of seronegative RA, ANCA-vasculitis, GERD, hiatal hernia s/p Linx, HTN, HLD, CVA, CAD, chronic hypoxemic respiratory failure, who presented to Hospital with weakness.   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Date of onset of symptoms: 8/21/2023 Symptoms present on admission: weakness, fatigue, vomiting,  Date of covid positive test: 8/23/2023 Vaccination status: vaccinated Imaging: CXR non-acute Oxygen requirements on admission: 2 Lpm by NC Current oxygen requirements: on RA  Medical therapy: Started on IV remdesivir and IV dexamethasone by ID Consultants following: ID Anticipated special isolation end date: 9/1/2023 Antiemetics PRN Acetaminophen PRN   Patient improved was on room air discharged home in stable condition   Metabolic acidosis: Resolved   Falls: PT/OT Care management   HLD: Statin   RA: Plaquenil   CAD: CVA: HTN: ASA, atorvastatin, Toprol   Depression: Zoloft
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Fall, Fatigue, Metabolic acidosis, Respiratory failure
Clinical narrative: Patient is a 75 y.o. female patient of CNP with history of seronegative RA, ANCA-vasculitis, GERD, hiatal hernia s/p Linx, HTN, HLD, CVA, CAD, chronic hypoxemic respiratory failure, who presented to Hospital with weakness.   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Date of onset of symptoms: 8/21/2023 Symptoms present on admission: weakness, fatigue, vomiting,  Date of covid positive test: 8/23/2023 Vaccination status: vaccinated Imaging: CXR non-acute Oxygen requirements on admission: 2 Lpm by NC Current oxygen requirements: on RA  Medical therapy: Started on IV remdesivir and IV dexamethasone by ID Consultants following: ID Anticipated special isolation end date: 9/1/2023 Antiemetics PRN Acetaminophen PRN   Patient improved was on room air discharged home in stable condition   Metabolic acidosis: Resolved   Falls: PT/OT Care management   HLD: Statin   RA: Plaquenil   CAD: CVA: HTN: ASA, atorvastatin, Toprol   Depression: Zoloft
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Patient is a 75 y.o. female patient of CNP with history of seronegative RA, ANCA-vasculitis, GERD, hiatal hernia s/p Linx, HTN, HLD, CVA, CAD, chronic hypoxemic respiratory failure, who presented to Hospital with weakness.   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Date of onset of symptoms: 8/21/2023 Symptoms present on admission: weakness, fatigue, vomiting,  Date of covid positive test: 8/23/2023 Vaccination status: vaccinated Imaging: CXR non-acute Oxygen requirements on admission: 2 Lpm by NC Current oxygen requirements: on RA  Medical therapy: Started on IV remdesivir and IV dexamethasone by ID Consultants following: ID Anticipated special isolation end date: 9/1/2023 Antiemetics PRN Acetaminophen PRN   Patient improved was on room air discharged home in stable condition   Metabolic acidosis: Resolved   Falls: PT/OT Care management   HLD: Statin   RA: Plaquenil   CAD: CVA: HTN: ASA, atorvastatin, Toprol   Depression: Zoloft
Age: 86.0
Sex: M
Vaccine: FLUA4, RSV
Symptoms: Mechanical ventilation
Clinical narrative: in hospital on ventilator
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Chills, Dyspnoea, Erythema, Fatigue, Feeling hot
Clinical narrative: Patient developed redness, swelling, pain, warm, fatigue, bodyaches, chills, shortness of breath, congestion, temperature of 99°F on the evening. The shot was given.  Patient was evaluated in clinic on July 28, the day after her vaccination. she no longer had chills. She continue to have bodyaches congestion headache. She also had 2 1/2 cm x 2 1/4 cm area of redness, warmth, and tenderness of the right upper arm near the shoulder.  Her constitutional symptoms resolved by 8/3/23.  I saw her in clinic on August 7 for another follow up. This time she had pain and a bump still present on her right upper arm. She was having difficulty sleeping at times because of her arm pain Her exam showed a 2 cm x 2.5 cm tender Red bump of the upper arm.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient developed redness, swelling, pain, warm, fatigue, bodyaches, chills, shortness of breath, congestion, temperature of 99°F on the evening. The shot was given.  Patient was evaluated in clinic on July 28, the day after her vaccination. she no longer had chills. She continue to have bodyaches congestion headache. She also had 2 1/2 cm x 2 1/4 cm area of redness, warmth, and tenderness of the right upper arm near the shoulder.  Her constitutional symptoms resolved by 8/3/23.  I saw her in clinic on August 7 for another follow up. This time she had pain and a bump still present on her right upper arm. She was having difficulty sleeping at times because of her arm pain Her exam showed a 2 cm x 2.5 cm tender Red bump of the upper arm.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Nasal congestion, Pain, Respiratory tract congestion, Sleep disorder, Swelling
Clinical narrative: Patient developed redness, swelling, pain, warm, fatigue, bodyaches, chills, shortness of breath, congestion, temperature of 99°F on the evening. The shot was given.  Patient was evaluated in clinic on July 28, the day after her vaccination. she no longer had chills. She continue to have bodyaches congestion headache. She also had 2 1/2 cm x 2 1/4 cm area of redness, warmth, and tenderness of the right upper arm near the shoulder.  Her constitutional symptoms resolved by 8/3/23.  I saw her in clinic on August 7 for another follow up. This time she had pain and a bump still present on her right upper arm. She was having difficulty sleeping at times because of her arm pain Her exam showed a 2 cm x 2.5 cm tender Red bump of the upper arm.
Age: 63.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given another dose of RSV 1 month after his first dose. Patient did not present with any symptoms but will follow up with him this week.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: hives back legs face body
Age: 62.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Blood albumin, Blood thyroid stimulating hormone, Fatigue, Feeling abnormal, Full blood count
Clinical narrative: She received a Flu shot at my office on 9/7/2023  She then went to pharmacy to receive her RSV in opposite arm on 9/7/2023.  The following day she developed a fever.  A couple days later, on 10th about 11 pm, she developed blisters all around her mouth  The blisters were persistently active for 4 days and filled with bloody material   On 9/15/2023, She  has had them starting to heal and they are scabbed over    Multiple blisters on bilateral mouth   Painful   She has had fatigue and malaise since the fever started  She came into medical facility on 9/15/2023 for a well exam and told Dr about the incident.  at that time photos were taken of her lips and top of mouth    The lips had multiple scabbed areas in the region of the vermilion border but she also had dry blood streaked on her tongue as well as mucosal blood in the roof of her mouth.  No petechia.   She was not feverish but she was feeling fatigued.   Dr called her on 17th to clarify history elements and learned that she is still feeling poorly  She will return to the office on Monday for labs
Age: 62.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Glycosylated haemoglobin, Laboratory test, Lip scab, Lipids, Malaise
Clinical narrative: She received a Flu shot at my office on 9/7/2023  She then went to pharmacy to receive her RSV in opposite arm on 9/7/2023.  The following day she developed a fever.  A couple days later, on 10th about 11 pm, she developed blisters all around her mouth  The blisters were persistently active for 4 days and filled with bloody material   On 9/15/2023, She  has had them starting to heal and they are scabbed over    Multiple blisters on bilateral mouth   Painful   She has had fatigue and malaise since the fever started  She came into medical facility on 9/15/2023 for a well exam and told Dr about the incident.  at that time photos were taken of her lips and top of mouth    The lips had multiple scabbed areas in the region of the vermilion border but she also had dry blood streaked on her tongue as well as mucosal blood in the roof of her mouth.  No petechia.   She was not feverish but she was feeling fatigued.   Dr called her on 17th to clarify history elements and learned that she is still feeling poorly  She will return to the office on Monday for labs
Age: 62.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Metabolic function test, Mouth haemorrhage, Oral mucosal blistering, Pain, Pyrexia
Clinical narrative: She received a Flu shot at my office on 9/7/2023  She then went to pharmacy to receive her RSV in opposite arm on 9/7/2023.  The following day she developed a fever.  A couple days later, on 10th about 11 pm, she developed blisters all around her mouth  The blisters were persistently active for 4 days and filled with bloody material   On 9/15/2023, She  has had them starting to heal and they are scabbed over    Multiple blisters on bilateral mouth   Painful   She has had fatigue and malaise since the fever started  She came into medical facility on 9/15/2023 for a well exam and told Dr about the incident.  at that time photos were taken of her lips and top of mouth    The lips had multiple scabbed areas in the region of the vermilion border but she also had dry blood streaked on her tongue as well as mucosal blood in the roof of her mouth.  No petechia.   She was not feverish but she was feeling fatigued.   Dr called her on 17th to clarify history elements and learned that she is still feeling poorly  She will return to the office on Monday for labs
Age: 62.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Scab
Clinical narrative: She received a Flu shot at my office on 9/7/2023  She then went to pharmacy to receive her RSV in opposite arm on 9/7/2023.  The following day she developed a fever.  A couple days later, on 10th about 11 pm, she developed blisters all around her mouth  The blisters were persistently active for 4 days and filled with bloody material   On 9/15/2023, She  has had them starting to heal and they are scabbed over    Multiple blisters on bilateral mouth   Painful   She has had fatigue and malaise since the fever started  She came into medical facility on 9/15/2023 for a well exam and told Dr about the incident.  at that time photos were taken of her lips and top of mouth    The lips had multiple scabbed areas in the region of the vermilion border but she also had dry blood streaked on her tongue as well as mucosal blood in the roof of her mouth.  No petechia.   She was not feverish but she was feeling fatigued.   Dr called her on 17th to clarify history elements and learned that she is still feeling poorly  She will return to the office on Monday for labs
Age: 55.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Cold sweat, Immediate post-injection reaction, Loss of consciousness, Malaise, Tremor
Clinical narrative: IMMEDIATELY AFTER ADMINISTERING THE SHINGRIX AND FLU SHOT PATIENT STATED HE WAS NOT FEELING WELL. I NOTIFIED THE PHARMACIST ON DUTY. PHARMACIST REPORTS PATIENT IS NOT FEELING WELL AND STARTS SHAKING ALMOST LIKE A TREMOR ,HE KEELED OVER IN THE BENCH CHAIR SIDEWAYS LOST CONSIOUSNESS VERY BRIEFLY AND ASKED TO CALL EMS. PATIENT SAT UPRIGHT REGAINED CONSIOUSNESS AND SAID FELT BETTER. PATIENT SAID WAS COLD AND SWEATY. HE ASKED FOR WATER . PARAMEDICS TOOK HIS VITALS AFTER ARRIVAL DID NOT SAY WHAT VITALS WERE BUT SAID WERE LOW SUGGESTED GOING TO HOSPITAL AND DECLINED . PATIENT WALKED OUT OF HERE AND SEEMED FINE.
Age: 76.0
Sex: F
Vaccine: FLUA4
Symptoms: Muscular weakness
Clinical narrative: Patient came in stating the next day her legs felt weak.  After an 1 to 2 hours patient was able to perform normal daily functions and and reported no other issues
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Histamine intolerance, Inflammation, Pain in extremity, Pruritus
Clinical narrative: MOST OF THE UPPER ARM BECAME RED, INFLAMMED AND WARM TO THE TOUCH. IT IS PAINFUL AND ITCHY AS WELL. PATIENT HAS BEEN TAKING IBUPROFEN AND USING ICE PACKS LOCALLY; ALSO STARTED TAKING BENADRYL TO MANAGE ITCHINESS/HISTAMINE RESPONSE. WILL FOLLOW UP WITH PATIENT IN 2 DAYS TO CHECK.
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Skin warm
Clinical narrative: MOST OF THE UPPER ARM BECAME RED, INFLAMMED AND WARM TO THE TOUCH. IT IS PAINFUL AND ITCHY AS WELL. PATIENT HAS BEEN TAKING IBUPROFEN AND USING ICE PACKS LOCALLY; ALSO STARTED TAKING BENADRYL TO MANAGE ITCHINESS/HISTAMINE RESPONSE. WILL FOLLOW UP WITH PATIENT IN 2 DAYS TO CHECK.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasms in quadraceps for weeks
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Injection site pain
Clinical narrative: Arm soreness began within hours. Arm soreness around injection site continued to get worse over the next 24 hours. On a scale of 1-10, I?d say a 3. Function impaired but not preventing using my arm.  Unable to sleep overnight. Restlessness. Chills occurred overnight and into the next morning. Temperature reading taken at time of a chill event was 99F. Mild headache, lethargy, tiredness, and body soreness. Daily function impaired but not blocked. The vaccine basically kicked my ass. Sore all over, tired, etc.  A slight cough existed as well. Began morning of 9/17.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Lethargy, Loss of personal independence in daily activities, Pain, Pain in extremity
Clinical narrative: Arm soreness began within hours. Arm soreness around injection site continued to get worse over the next 24 hours. On a scale of 1-10, I?d say a 3. Function impaired but not preventing using my arm.  Unable to sleep overnight. Restlessness. Chills occurred overnight and into the next morning. Temperature reading taken at time of a chill event was 99F. Mild headache, lethargy, tiredness, and body soreness. Daily function impaired but not blocked. The vaccine basically kicked my ass. Sore all over, tired, etc.  A slight cough existed as well. Began morning of 9/17.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: Arm soreness began within hours. Arm soreness around injection site continued to get worse over the next 24 hours. On a scale of 1-10, I?d say a 3. Function impaired but not preventing using my arm.  Unable to sleep overnight. Restlessness. Chills occurred overnight and into the next morning. Temperature reading taken at time of a chill event was 99F. Mild headache, lethargy, tiredness, and body soreness. Daily function impaired but not blocked. The vaccine basically kicked my ass. Sore all over, tired, etc.  A slight cough existed as well. Began morning of 9/17.
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Pain
Clinical narrative: CONTINUED PAIN LIFTING UP LEFT ARM ABOVE SHOULDER HEIGHT SINCE OCTOBER 2022.
Age: 87.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Discomfort, Myalgia
Clinical narrative: Muscle aches, soreness and joint pain on the injected arm were experienced for roughly 3 days. Took APAP otc to alleviate the pain and was recommended to move the arm around and stretch it to help with blood flow.  By the evening of the 3rd day the pain and discomfort did go away and was feeling much better. Followed up a week later and patient was doing okay with no complaints.
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Lymphadenopathy, Urticaria
Clinical narrative: Hives on face first, then back, top of feet, swollen neck after 12 hours, and left armpit lymph swollen for 2 days.
Age: 50.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Brain fog, Decreased appetite, Fatigue, Hypersomnia, Loss of personal independence in daily activities
Clinical narrative: I got the shingrix and prevnar20 shots at around 5:30PM Friday evening.  On Saturday morning, about 12-14 hours after the shots, I woke up groggy, achey, and feeling feverish.  At 7AM my temp was 100.2, and by 10AM it was 102.1.  I had a fever that responded briefly to tylenol (for about 2 hours) but came back and ranged from 101-102 for the rest of the day and night.  The fever broke around 3AM the following night (almost 36 hours after receiving the vaccines).  With the fever was brain fog, full body aches, extreme fatigue, anorexia, and some nausea.  I slept all day and was essentially incapacitated, unable to do activities of daily living.  The symptoms mostly resolved by Sunday morning, with some residual fatigue that faded through the day.
Age: 50.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Nausea, Pain, Pyrexia, Somnolence
Clinical narrative: I got the shingrix and prevnar20 shots at around 5:30PM Friday evening.  On Saturday morning, about 12-14 hours after the shots, I woke up groggy, achey, and feeling feverish.  At 7AM my temp was 100.2, and by 10AM it was 102.1.  I had a fever that responded briefly to tylenol (for about 2 hours) but came back and ranged from 101-102 for the rest of the day and night.  The fever broke around 3AM the following night (almost 36 hours after receiving the vaccines).  With the fever was brain fog, full body aches, extreme fatigue, anorexia, and some nausea.  I slept all day and was essentially incapacitated, unable to do activities of daily living.  The symptoms mostly resolved by Sunday morning, with some residual fatigue that faded through the day.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Left arm itchy, red, swollen and painful
Age: 79.0
Sex: M
Vaccine: FLU4, RSV, VARZOS
Symptoms: Amnesia, Impaired work ability, Loss of consciousness, Malaise
Clinical narrative: Patient was feeling fine the day of receiving 3 shots (afternoon time between  3pm and 4pm possibly of 09/15/2023). Patient says that he received 2 shots in one arm and 1 shot in the other. The next day the patient did not feel like himself. He went to work and could not work the whole day. He probably worked about 3 hours from being there around 8am. He could not set up his table at work as usual. Patient believed that he blacked out upon arriving back home. He found his van in an unusual spot by his home. He doesn't remember any of that from yesterday (parking his van home and getting home). He felt really down the next day (09/16/2023-SAT).  He did not go to work today (09/17/2023). He says he has lost track of time especially remembering who he was on the phone with and when from yesterday afternoon. He states that people were calling him and he was unaware yesterday. He had a hard time getting out of bed this morning. Patient is starting to feel better today though.
Age: 75.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came in for flu and RSV vaccines and was administer flu and Shingrix (in error). No known physical adverse reaction occurred.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site joint pain
Clinical narrative: Received COVID booster yesterday, causing sudden onset (L) shoulder joint pain; suspect vaccine may have been given intra-articularly.
Age: 76.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came in for flu and RSV vaccs and was administered flu and shingles (in error). No known adverse reaction occurred.
Age: 80.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Endotracheal intubation, Guillain-Barre syndrome, Lumbar puncture, Mobility decreased, Paralysis
Clinical narrative: Guillian Barre Syndrome; paralyzed from the eyes down; problems walking/relearn to walk; had to relearn to talk, swallow and walk; had to relearn to talk, swallow and walk; This serious case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose in January 2023 via intramuscular route in unknown arm, 0.5 ml and no adverse effects from the first Shingrix vaccine).   On 28-APR-2023, the patient received the 2nd dose of Shingrix (intramuscular, right arm) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Guillian Barre Syndrome) (serious criteria hospitalization and GSK medically significant), paralysis (Verbatim: paralyzed from the eyes down) (serious criteria hospitalization and GSK medically significant), walking difficulty (Verbatim: problems walking/relearn to walk) (serious criteria hospitalization), speech disorder (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization) and swallowing difficult (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization).The outcome of the guillain barre syndrome was not resolved and the outcome of the paralysis, walking difficulty, speech disorder and swallowing difficult were not reported.   It was unknown if the reporter considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.     It was unknown if the company considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-SEP-2023 The reporter reported that he received his Shingrix vaccine in the right arm.  The reporter reported that 1 week after receiving the Shingrix vaccine he started to have problems walking. Two weeks after receiving his Shingrix vaccine he was paralyzed from the eyes down.  The reporter reported that he was in the hospital for 10 weeks, in rehab for 31 days and now in rehab at home.  The reporter reported that he had to relearn to talk, swallow and walk. The reporter reported he must use a walker to walk.  The reporter reported that his neurologist diagnosed him with Guillian Barre Syndrome (via spinal tap). The patient also asked for the GlaxoSmithKline Legal Department to sue for assistance with bills. The reporter consented to follow up.
Age: 80.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Dysphagia, Gait disturbance, Guillain-Barre syndrome, Paralysis, Speech disorder
Clinical narrative: Guillian Barre Syndrome; paralyzed from the eyes down; problems walking/relearn to walk; had to relearn to talk, swallow and walk; had to relearn to talk, swallow and walk; This serious case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose in January 2023 via intramuscular route in unknown arm, 0.5 ml and no adverse effects from the first Shingrix vaccine).   On 28-APR-2023, the patient received the 2nd dose of Shingrix (intramuscular, right arm) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Guillian Barre Syndrome) (serious criteria hospitalization and GSK medically significant), paralysis (Verbatim: paralyzed from the eyes down) (serious criteria hospitalization and GSK medically significant), walking difficulty (Verbatim: problems walking/relearn to walk) (serious criteria hospitalization), speech disorder (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization) and swallowing difficult (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization).The outcome of the guillain barre syndrome was not resolved and the outcome of the paralysis, walking difficulty, speech disorder and swallowing difficult were not reported.   It was unknown if the reporter considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.     It was unknown if the company considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-SEP-2023 The reporter reported that he received his Shingrix vaccine in the right arm.  The reporter reported that 1 week after receiving the Shingrix vaccine he started to have problems walking. Two weeks after receiving his Shingrix vaccine he was paralyzed from the eyes down.  The reporter reported that he was in the hospital for 10 weeks, in rehab for 31 days and now in rehab at home.  The reporter reported that he had to relearn to talk, swallow and walk. The reporter reported he must use a walker to walk.  The reporter reported that his neurologist diagnosed him with Guillian Barre Syndrome (via spinal tap). The patient also asked for the GlaxoSmithKline Legal Department to sue for assistance with bills. The reporter consented to follow up.
Age: 80.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Walking aid user
Clinical narrative: Guillian Barre Syndrome; paralyzed from the eyes down; problems walking/relearn to walk; had to relearn to talk, swallow and walk; had to relearn to talk, swallow and walk; This serious case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose in January 2023 via intramuscular route in unknown arm, 0.5 ml and no adverse effects from the first Shingrix vaccine).   On 28-APR-2023, the patient received the 2nd dose of Shingrix (intramuscular, right arm) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Guillian Barre Syndrome) (serious criteria hospitalization and GSK medically significant), paralysis (Verbatim: paralyzed from the eyes down) (serious criteria hospitalization and GSK medically significant), walking difficulty (Verbatim: problems walking/relearn to walk) (serious criteria hospitalization), speech disorder (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization) and swallowing difficult (Verbatim: had to relearn to talk, swallow and walk) (serious criteria hospitalization).The outcome of the guillain barre syndrome was not resolved and the outcome of the paralysis, walking difficulty, speech disorder and swallowing difficult were not reported.   It was unknown if the reporter considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.     It was unknown if the company considered the guillain barre syndrome, paralysis, walking difficulty, speech disorder and swallowing difficult to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-SEP-2023 The reporter reported that he received his Shingrix vaccine in the right arm.  The reporter reported that 1 week after receiving the Shingrix vaccine he started to have problems walking. Two weeks after receiving his Shingrix vaccine he was paralyzed from the eyes down.  The reporter reported that he was in the hospital for 10 weeks, in rehab for 31 days and now in rehab at home.  The reporter reported that he had to relearn to talk, swallow and walk. The reporter reported he must use a walker to walk.  The reporter reported that his neurologist diagnosed him with Guillian Barre Syndrome (via spinal tap). The patient also asked for the GlaxoSmithKline Legal Department to sue for assistance with bills. The reporter consented to follow up.